XtraCare Foaming Facial Cleanser

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: XtraCare Foaming Facial Cleanser
Generic name: TRICLOSAN
Manufacturer: Rejoice International
Product type: HUMAN OTC DRUG
SPL set ID: 313fcd4a-8641-417e-bf0b-02359ad815fe
SPL ID: 126d79f0-68eb-8a53-e063-6294a90a6fe1
Version: 3
Effective date: 2024-02-28
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:52:44

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M016	openfda.application_number
brand name		XtraCare Foaming Facial Cleanser	openfda.brand_name
generic name		TRICLOSAN	openfda.generic_name
manufacturer name		Rejoice International	openfda.manufacturer_name
ndc	package	57337-036-01	openfda.package_ndc
ndc	product	57337-036	openfda.product_ndc
ndc11	package	57337003601	derived:openfda.package_ndc
spl id		126d79f0-68eb-8a53-e063-6294a90a6fe1	id
spl set id		313fcd4a-8641-417e-bf0b-02359ad815fe	set_id
unii		4NM5039Y5X	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product avoid contact with eyes. if eye contact occurs, immediately flush with water. Stop use and ask a doctor if excessive skin irritation develops or condition worsens symptoms last more than 7 days or clear up and occur again within a few days

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.